Evaluation of Oral Needs of Children With Disorder Attention Deficit/Hyperactivity Disorder

Brief Summary

Official Title: “Evaluation of Oral Needs of Children With Disorder Attention Deficit/Hyperactivity Disorder”

There is little accurate data in the literature at present on oral problems of hyperactive children, especially regarding care needs that would justify an assumption oral specific. The purpose of this study is therefore to have accurate data regarding the risk of caries, other oral diseases like periodontal disease, trauma, and assess the needs dental care and problems in cooperation for dental care in a population of children and adolescents with hyperactivity disorder with attention deficit. Finally, it has recently been described as the sleep disordered breathing was not uncommon in disorder attention deficit/hyperactivity disorder, whether snoring and/or apnea. But it is now accepted that some features of facial morphology favoring pharyngeal congestion occur in individuals with obstructive sleep apnea (hyperdivergent typology with increased anterior facial height and decreased posterior facial height, becoming the facial retrognathia, pharyngeal congestion, elongation and thickening of the soft palate, low position of the hyoid bone). A cephalometric analysis of craniofacial architecture and relationships with the soft tissue surrounding skeletal structures will detect if any of these specific characteristics that could promote sleep disordered breathing are found in disorder attention deficit/hyperactivity disorder prevalence with a particular.

  • Study Type: Observational
  • Study Design: Observational Model: Cohort, Time Perspective: Prospective
  • Study Primary Completion Date: April 2013

Arms, Groups and Cohorts in this Clinical Trial

  • test cohort
    • Evaluation of oral health needs of children with attention deficit disorder with or without hyperactivity
  • not disorder cohort
    • children without attention deficit disorder

Outcome Measures for this Clinical Trial

Primary Measures

  • Cod and CAOD index for caries,PI and GI indices for periodontal disease, dysfunction and malocclusion classification by WHO and Analysis cephalometric
    • Time Frame: 18 months
      Safety Issue?: No

Secondary Measures

  • Measurement of anxiety through the CFSS-DS scale (Dental subscale of Children’s Fear Survey Schedule, Schedule 1)
    • Time Frame: 18 months
      Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria

  • Consent signed by parents before the examination
  • With of a social security scheme
  • Age greater than or equal to 5 years and less than 15 years, Children with a diagnosis of attention deficit / hyperactivity confirmed or made by a physician specialists co-investigators of the study, diagnosis defined according to precise criteria for a disorder attention deficit/hyperactivity disorder as specified in DSM-IV with a normal IQ, ie higher than 80, and without other neurological or psychiatric
  • Child consultant in a hospital or doctors' offices

Exclusion Criteria

  • Refusal of consent of the parents
  • No affiliation to a social security scheme
  • Age below 5 years or more than 15 years
  • Diagnosis of a disorder attention deficit/hyperactivity disorder not confirmed by a physician , IQ <80, Pathology associated neurological or psychiatric

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 5 Years

Maximum Age for this Clinical Trial: 15 Years

Are Healthy Volunteers Accepted for this Clinical Trial: Accepts Healthy Volunteers

Clinical Trial Investigator Information

  • Lead Sponsor
    • University Hospital, Strasbourg, France
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • MANIERE Marie-Cécile, MD, Principal Investigator, not affiliated
  • Overall Contact(s)
    • MANIERE Marie-Cécile, MD, 33390243887, Maniere.Marie-Cecile@chru-strasbourg.fr


Clinical Trials content is provided directly by the US National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of information about a specific clinical trial contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: